Consider Buprenorphine for Chronic Pain in Some Patients

November 2021

You’ll see growing interest in buprenorphine (Belbuca, Butrans, etc) for chronic pain...partly to reduce opioid risks.

Buprenorphine is a partial agonist at mu-opioid receptors...and an ANTagonist at other opioid receptors.

That’s why it seems to hit a ceiling that limits respiratory depression...may cause less euphoria compared to full opioid agonists (morphine, etc)...and may have less potential for misuse.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Clarify When and How to Give COVID-19 Vaccine Boosters
Aspirin Expect Hype About New Vazalore Aspirin Capsules
Neurology & Pain Emphasize Nondrug Strategies After a Concussion
Cholesterol Don’t Jump to Meds for Patients With Elevated Triglycerides
Pregnancy Ease Concerns Over Acetaminophen in Pregnancy
Neurology & Pain Consider Buprenorphine for Chronic Pain in Some Patients
Hair Loss Set Expectations for Male Pattern Baldness Meds
Nephrology Don’t Consider CrCl and eGFR Interchangeable
Veterinary Medicine Be Familiar With Nuances for Safe Med Use in Cats and Dogs

Consider Buprenorphine for Chronic Pain in Some Patients

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents